Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors—an advance ...
May 8, 2024
0
11
A head-mounted device that generates an ultra-low frequency ultra-low magnetic field has been found to improve the symptoms of four male patients diagnosed with major depressive disorder. Future trials using the device may ...
May 8, 2024
0
20
Researchers at the Icahn School of Medicine at Mount Sinai have shed valuable light on the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to produce potential therapeutic ...
May 8, 2024
0
12
A team of Dana-Farber Cancer Institute investigators discovered that a subset of myeloid and lymphoid leukemias depend on a molecular complex called PI3Kgamma for survival. The study provides both mechanistic and preclinical ...
May 8, 2024
0
42
Do dying patients have a "right to try" illegal drugs such as psilocybin and MDMA if they might alleviate end-of-life suffering from anxiety and depression?
May 8, 2024
0
15
The most socially vulnerable counties are less likely to have any cancer clinical trial, according to a research letter published online May 7 in JAMA Network Open.
May 8, 2024
0
0
Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels. Their findings, recently published in Circulation, could lead to new therapies for people with ...
May 7, 2024
0
11
Inflammatory bowel disease (IBD) is a complex condition that requires individualized care to meet the needs of the patient's current disease state. With available medications sometimes causing serious side effects or losing ...
May 7, 2024
0
64
Blindness and paralysis are often the devastating consequences of little-known disease myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). An Australian research collaboration is looking to change this, ...
May 7, 2024
0
5
Researchers from Griffith University's National Center for Neuroimmunology and Emerging Diseases (NCNED) have made a discovery that could bring relief to those struggling with long COVID.
May 7, 2024
0
3
